ETEman H. Thabetb

Eman H. Thabetb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eman H. Thabetb has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hepatic FerriScan in Evaluating Iron Overload in Pediatric Sickle Cell Disease

    by Eman A. Elbostany, Eman A. Elghoroury, Nehal Abdelhamid, Hanan M. Hamed, Eman H. Thabetb, Hadeel M. Seif El Dein, Amany M. Abd Al-Aziz, Shereen H. Abd El Aziz, Sonia A. Habib, Eman Eltahlawy

  • Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers

    by Fatina I. Fadel, Manal F. Elshamaa, Safaa M. Abdel-Rahman, Eman H. Thabet, Solaf Kamel, Dina Kandil, Mona H. Ibrahim, Mostafa El-Ahmady

    This study aimed to assess whether markers of coagulation, fibrinolysis or thrombophilia are increased in children on haemodialysis compared with controls and whether measurement of any of these factors could help to identify patients at an increased risk of arteriovenous fistula (AVF) occlusion. Blood samples were taken from 55 children immediately before a session of haemodialysis and from 20 healthy volunteers. Thrombin–antithrombin (TAT), D-dimer, plasmin–antiplasmin (PAP) and anticardiolipin immunoglobulin G (ACA-Ig G) were measured by ELISA. Factor V Leiden mutation (G1691A) was determined by gene polymorphism [restriction fragment length polymorphism (RFLP)]. Determination of the patency of the AVF was prospectively followed up for a minimum of 4 years or until the AVF was nonfunctioning. Fifty-five patients were studied with a median follow-up of 659 days (range 30–1670 days). A significant increase was found in the levels of D-dimer, PAP and ACA-Ig G in haemodialysis patients with thrombosed and nonthrombosed native AVFs vs. controls. There was a significant difference between both chronic haemodialysis patients with thrombosed and nonthrombosed native AVF with regard to ACA-IgG levels. At 1 year follow-up, primary patency was 61.4% (27 patients). In multivariate analysis, D-dimer was inversely associated with secondary patency. Thrombophilia may predispose children with end stage renal disease to access failure. The promising finding is that in children on haemodialysis, D-dimer levels were increased and inversely correlated with secondary patency. Further evaluation is required into the possible role of D-dimer as a biomarker of AVF occlusion.


  • Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis

    by Gamila S. M. El-Saeed, Fatina Fadel, Manal F. Elshamaa, Rasha E. E. Galal, Eman A. Elghoroury, Soha A. Nasr, Eman H. Thabet, Safaa M. Abdelrahman

    (2015). Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis. Renal Failure: Vol. 37, No. 9, pp. 1452-1456. doi: 10.3109/0886022X.2015.1077317


  • Open Access

    Interactive Effects of Immunoglobulin Gamma and Human Leucocyte Antigen Genotypes on Response to Interferon Based Therapy of Hepatitis C Virus

    by Howayda E. Gomaa, Mohamed Mahmoud, Nevine E. Saad, Amal S. Saad-Hussein, Somaia Ismail, Eman H. Thabet, Hebatallah Farouk, Dina Kandil, Ahmed Heba, Wael Hafez

    AIM: We examined the role that immunoglobulin GM 23 and KM allotypes—genetic markers of γ and κ chains, respectively—play in response to treatment of hepatitis C virus (HCV) infection in Egyptian patients.MATERIAL AND METHODS: A total of 120 persons who had responded to HCV treatment and 125 with persistent HCV infection were genotyped for the presence of GM23 and KM determinants. HLA –C genotyping was also done.RESULTS: Association of GM 23+ and KM3 was significantly associated with non response to treatment (P < 0.0001). Individuals who lacked this GM genotype (but were positive for KM1,2 and 3) were likely to respond to treatment (P=0.045). Association of heterozygous GM23 (+/-) with KM 1,2 and 3 or KM3 alone was significantly associated with SVR (P = 0.001) and (P = 0.0001) respectively. Particular combinations of HLA and GM genotypes were associated significantly with the response to HCV treatment. The combination of HLAC2C2 and GM23+ was associated with persistence of infection (P = 0.027) while the association of HLAC2C2 and heterozygous GM23+/- was associated with SVR (P = 0.001).The association of HLAC1C1 and heterozygous GM23+/- was significantly associated with SVR (P = 0.001) and also subjects with HLA C1/C2 and heterozygous GM23+/- were likely to respond to treatment (P = 0.003) while subjects with HLA C1/C2 and GM23+ show tendency to resist to treatment (P = 0.0001).CONCLUSION: Our results didn’t support a role for KM allotypes, GM23 allotype plays a role in the persistence of HCV infection in the presence or absence of KM1,3. Interaction between certain GM and HLA-C genotypes may favor adequate response to interferon based therapies.

  • Open Access

    Impact of IL-10 (-1082) Promoter–Single Nucleotide Polymorphism on the Outcome of Hepatitis C Virus Genotype 4 Infection

    by Soheir F. Helal, Howayda E. Gomaa, Eman H. Thabet, Mariam A. Younan, Neveen A. Helmy

    Immuneregulatory cytokines may influence the hepatitis C virus (HCV) infection outcome. This study aimed to determine the genotypic and allelic frequencies of the interleukin (IL)-10 (-1082) G/A polymorphism, and its association with chronicity or resolution of HCV genotype 4 infection in Egypt. The frequencies of different dimorphic polymorphisms based on single nucleotide substitution in chronic HCV patients (50) and resolved HCV patients (50) were: IL-10 (-1082) G/G 22 (44%) and 18 (36%), G/A 19 (38%) and 24 (48%), and A/A 9 (18%), and 8 (16%), respectively. In the sustained virologic response (SVR) (36) and spontaneously resolved subjects (14) groups, the frequencies were: IL-10 (-1082) G/G 11 (30.6%) and 7 (50%) G/A 18 (50%) and 6 (42.9%), A/A 7 (19.4%) and 1 (7.1%), respectively. An association between male gender and chronic hepatitis C outcome ( P value 0.041) was found. However, no significant gender difference was found when we compared females versus males with elevated alanine transaminase (ALT) levels in the chronic HCV patient group ( P value = 1).Conclusion: No significant difference in the frequency of IL-10 single nucleotide polymorphism (SNP) at position 1082 was found between chronic and resolved HCV subjects.


  • Open Access

    Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus

    by Heba S. Assal, Salwa Tawfeek, Enas A. Rasheed, Dalia El-Lebedy, Eman H. Thabet

    Renal tubulointerstitium plays an important role in the development and progression of diabetic nephropathy. The aim of this study was to assess serum cystatin C and 2 renal tubular enzymes, neutrophil gelatinase associated lipocalin (NGAL) and N-acetyl-beta-D-glucosaminidase (NAG), as screening markers for early renal dysfunction in patients with type 2 diabetes mellitus (T2DM). ROC curve analysis showed that urinary NAG is the most sensitive marker of microalbuminuria and early renal damage with sensitivity of 83.3%, while serum cystatin C was the most sensitive and specific marker of macroalbuminuria and damage progress with sensitivity of 70.8% and specificity of 83.3% versus 70.6% and 83.3% for uNGAL; and 64.7% and 66.7% for NAG, respectively. Our data indicate that urinary NAG is the most sensitive marker for early renal damage in diabetic patients. However, for damage progress, serum cystatin C is the most sensitive and specific marker for follow-up and monitoring renal dysfunction.


  • Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease

    by Manal F. Elshamaa, Samar Sabry, Ahmed Badr, Mostafa El-Ahmady, Eman A. Elghoroury, Eman H. Thabet, Dina Kandil, Solaf Kamel

    Nitric oxide production is reduced in renal disease, partially due to decreased endothelial nitric oxide production. Evidence indicates that nitric oxide deficiency contributes to cardiovascular events and progression of kidney damage. A polymorphism in intron 4 of the endothelial constitutive nitric oxide synthase (ecNOS) gene is a candidate gene in cardiovascular and renal diseases. We investigated a potential involvement of this polymorphism in chronic renal failure. A case–control study involved 78 children with chronic kidney disease (CKD) and 30 healthy controls. All participants were genotyped for the ecNOS4 polymorphism by the polymerase chain reaction (PCR). Dialyzed (maintenance hemodialysis) and conservative treatment children had significantly higher frequency of the aa genotype and ecNOS4a allele (P < 0.05) compared with controls. The combined genotype aa + ab vs. bb comparison validated that a allele is a high-risk allele for end-stage renal disease (ESRD) (P < 0.05). Serum nitric oxide level was found to be lower in carriers of the ecNOS 4a allele than in noncarriers (100.29 ± 27.32 vs. 152.73 ± 60.39 μmol/l, P = 0.04). Interestingly, 85.95% of the ecNOS 4a allele ESRD patients were found hypertensive in comparison to the 60.67% patients of non noncarriers (bb genotype) (P = 0.04). Also, 35.90% of the ecNOS 4a allele ESRD patients were found to have cardiovascular disease in comparison to the 5.13% patients of noncarriers (bb genotype) (P = 0.01). On multiple linear regression analysis, a allele was independently associated with hypertension (P = 0.03). There was a significantly higher frequency of the ecNOS4a allele carriers among CKD children, both on MHD and conservative treatment than in controls. This suggests that the ecNOS gene polymorphism may be associated with an increased risk of chronic renal failure.


  • Extended spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli strains in a pediatric teaching hospital in Egypt

    by Amani A. El Kholy, Howayda E. Gomma, Mariam A. Younan, Eman H. Thabet, Mona M.A. Haleim, Mervat G. El Anany, Ahmed A.S. Hendeya

    Objective The aim of this study is to study the prevalence of extended spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBL-E) and Klebsiella pneumoniae (ESBL-K) and the clonality of isolates causing nosocomial infections in our hospital. Materials and methods A cross-sectional study was conducted; clinical isolates of E. coli and K. pneumoniae were screened for ESBL production. In addition, the clonal relationship of nosocomial ESBL-E and ESBL-K was studied by biotyping and antimicrobial susceptibility testing, which was confirmed by pulsed-field gel electrophoresis. Results Of the 5976 clinical specimens (3048 blood, 1296 urine, 924 sputum, 312 pus, 396 other types of specimens) submitted for bacterial culture, a total of 156 E. coli and 300 K. pneumoniae were isolated. ESBL-E and ESBL-K represented 86% and 68.3%, respectively, of the total E. coli and K. pneumoniae. Antimicrobial susceptibility testing to non-β-lactam agents, including amikacin, gentamicin, cotrimoxazole, and ciprofloxacin, for ESBL-E were 75.7%, 79.4%, 19.7%, and 100%, respectively, and for ESBL-K were 66.5%, 42%, 24.3%, and 31%, respectively. Ten (7.5%) of the 134 ESBL-E and 29 (15%) of the 192 ESBL-K proved to be identical by biotyping and antimicrobial susceptibility testing. Pulsed-field gel electrophoresis of the identical isolates revealed two and seven clones, respectively. Conclusion The results of this study suggest the endemicity of ESBL-producing K. pneumoniae and E. coli strains and the dissemination of a plasmid rather than the occurrence of a clonal outbreak during the study period.


  • Open Access

    Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease

    by Manal F Elshamaa, Samar M Sabry, Hafez M Bazaraa, Hala M Koura, Eman A Elghoroury, Nagwa A Kantoush, Eman H Thabet, Dalia A Abd-El Haleem

    We investigated the association between polymorphisms of the angiotensin converting enzyme-1 (ACE-1) and angiotensin II type one receptor (AT1RA1166C) genes and the causation of renal disease in 76 advanced chronic kidney disease (CKD) pediatric patients undergoing maintenance hemodialysis (MHD) or conservative treatment (CT). Serum ACE activity and creatine kinase-MB fraction (CK-MB) were measured in all groups. Left ventricular mass index (LVMI) was calculated according to echocardiographic measurements. Seventy healthy controls were also genotyped. The differences of D allele and DI genotype of ACE were found significant between MHD group and the controls (p = 0.0001). ACE-activity and LVMI were higher in MHD, while CK-MB was higher in CT patients than in all other groups. The combined genotype DD v/s ID+II comparison validated that DD genotype was a high risk genotype for hypertension .~89% of the DD CKD patients were found hypertensive in comparison to ~ 61% of patients of non DD genotype(p = 0.02). The MHD group showed an increased frequency of the C allele and CC genotype of the AT1RA1166C polymorphism (P = 0.0001). On multiple linear regression analysis, C-allele was independently associated with hypertension (P = 0.04). ACE DD and AT1R A/C genotypes implicated possible roles in the hypertensive state and in renal damage among children with ESRD. This result might be useful in planning therapeutic strategies for individual patients.